US government awards Moderna $176M for bird flu vaccine development

• The U.S. government has awarded $176 million to Moderna to develop its bird flu vaccine as the country faces an H5N1 outbreak in dairy cows. • Funds from the U.S. Biomedical Advanced Research and Development Authority will support late-stage development and testing of the vaccine. • U.S. officials said that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial. The U.S. government has awarded $176 million to Moderna to advance development of its bird flu vaccine, the company said on...